TN SB2361 | 2023-2024 | 113th General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 30 2024 - 25% progression, died in committee
Action: 2024-03-12 - Assigned to General Subcommittee of Senate Commerce and Labor Committee
Pending: Senate Commerce and Labor Committee
Text: Latest bill text (Draft #1) [PDF]
Status: Introduced on January 30 2024 - 25% progression, died in committee
Action: 2024-03-12 - Assigned to General Subcommittee of Senate Commerce and Labor Committee
Pending: Senate Commerce and Labor Committee
Text: Latest bill text (Draft #1) [PDF]
Summary
As introduced, prohibits health carriers, health benefit plans, or utilization review organizations from using step therapy protocols as a basis to restrict, delay, or deny coverage for a prescription drug or drug regimen for the treatment of cancer and associated conditions if certain criteria are met. - Amends TCA Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71.
Title
AN ACT to amend Tennessee Code Annotated, Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to prescription drugs.
Sponsors
| Sen. Bo Watson [R] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-03-12 | Senate | Assigned to General Subcommittee of Senate Commerce and Labor Committee |
| 2024-03-08 | Senate | Placed on Senate Commerce and Labor Committee calendar for 3/12/2024 |
| 2024-03-06 | Senate | Placed on Senate Commerce and Labor Committee calendar for 3/12/2024 |
| 2024-03-05 | Senate | Action deferred in Senate Commerce and Labor Committee to 3/12/2024 |
| 2024-02-27 | Senate | Placed on Senate Commerce and Labor Committee calendar for 3/5/2024 |
| 2024-02-01 | Senate | Passed on Second Consideration, refer to Senate Commerce and Labor Committee |
| 2024-01-31 | Senate | Introduced, Passed on First Consideration |
| 2024-01-30 | Senate | Filed for introduction |
Same As/Similar To
HB2213 (Crossfiled) 2024-01-31 - Assigned to s/c Insurance Subcommittee
